MIRM – mirum pharmaceuticals, inc. - common stock (US:NASDAQ)
Stock Stats
News
11/15
08:48 am
mirm
Medium
Analysts Are Updating Their Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Estimates After Its Third-Quarter Results [Yahoo! Finance]
11/14
08:22 am
mirm
Low
Mirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD's The Liver Meeting [Yahoo! Finance]
11/14
08:00 am
mirm
Low
Mirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD’s The Liver Meeting
11/14
05:54 am
mirm
Low
Mirum Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/13
02:43 pm
mirm
Low
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $66.00 price target on the stock.
11/12/2024
08:00 am
mirm
0.5%
BEAT
8/7/2024
04:01 pm
mirm
2.3%
MISS
5/8/2024
04:02 pm
mirm
3.2%
MISS
11/13
02:43 pm
Reiterates
Buy
Buy
HC Wainwright
Low
-0.9%
11/13
12:48 pm
Maintains
Buy
Buy
Citigroup
Low
0.9%
11/13
12:48 pm
Maintains
Buy
Buy
Citigroup
Low
0.9%
11/13
07:20 am
Maintains
Outperform
Outperform
Baird
Low
2.9%
11/13
07:20 am
Maintains
Outperform
Outperform
Baird
Low
2.9%
11/15
05:35 pm
mirm
Medium
Form 4 Mirum Pharmaceuticals, For: Nov 14 Filed by: Howe Jolanda
11/14
04:38 pm
mirm
Medium
Form SC 13G/A Mirum Pharmaceuticals, Filed by: BIOTECHNOLOGY VALUE FUND L P
11/14
04:37 pm
mirm
Medium
Form 4 Mirum Pharmaceuticals, For: Nov 08 Filed by: Quan Joanne
11/14
04:35 pm
mirm
Medium
Form 4 Mirum Pharmaceuticals, For: Nov 08 Filed by: BJERKHOLT ERIC
11/14
04:33 pm
mirm
Medium
Form 4 Mirum Pharmaceuticals, For: Nov 08 Filed by: Peetz Christopher
Show more
Top News Gainers
12/13 Mirum Pharmaceuticals to Provide Regulatory Update in Upcoming Conference Call and Webcast 111.0%
3/23 Form 4 Mirum Pharmaceuticals, For: Mar 19 Filed by: Tucker Edwin Jonathan 20.8%
3/12 Form 10-K Mirum Pharmaceuticals, For: Dec 31 16.2%
1/16 Frazier Healthcare Partners Closes Oversubscribed $617 Million Life Sciences Fund 15.2%
12/7 Mirum Pharmaceuticals (NASDAQ: MIRM) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 11.2%
4/17 Mirum Pharmaceuticals (NASDAQ: MIRM) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 6.0%
4/28 Mirum Pharmaceuticals Appoints Peter Radovich as Chief Operating Officer 5.5%
4/30 Form 3 Mirum Pharmaceuticals, For: Apr 28 Filed by: Radovich Peter 5.4%
2/18 Mirum Pharmaceuticals to Participate at Four Upcoming Conferences 5.0%
4/9 Mirum Pharmaceuticals (NASDAQ: MIRM) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $15.00 price target on the stock. 4.7%
Top News Decliners
3/17 Mirum Pharmaceuticals (MIRM) Investor Presentation - Slideshow [Seeking Alpha] -10.7%
1/8 Mirum Pharmaceuticals Announces Pricing of Public Offering -6.6%
1/6 Form S-1 Mirum Pharmaceuticals, -6.0%
12/17 Mirum Pharmaceuticals (NASDAQ: MIRM) had its price target raised by analysts at Citigroup Inc from $21.00 to $30.00. They now have a "buy" rating on the stock. -5.8%
4/16 Mirum Pharmaceuticals (NASDAQ: MIRM) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $17.00 price target on the stock. -5.6%
1/9 Form 424B4 Mirum Pharmaceuticals, -5.0%
8/28 Mirum Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update -4.8%
8/12 Mirum Pharmaceuticals (NASDAQ: MIRM) is now covered by analysts at Citigroup Inc. They set a "buy" rating on the stock. -4.6%
12/28 Mirum Pharmaceuticals (NASDAQ: MIRM) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -4.4%
9/26 Mirum Pharmaceuticals to Present at Cantor 2019 Global Healthcare Conference -3.9%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3